Skip to main content
logo
Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
22.32
-1.58 (-6.61%)
Sep 30, 2026, 12:15 PM EDT - Market open

Apnimed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
115.1238.478.01-1
Revenue Growth
-380.12%---
Cost of Revenue
7.026.693.37--
Gross Profit
108.131.774.64-1
Selling, General & Admin
31.8523.4921.511.316.63
Research & Development
40.3862.197.3837.2120.92
Operating Expenses
72.2385.59118.8848.5227.55
Operating Income
35.87-53.82-114.23-48.52-26.55
Interest & Investment Income
1.861.415.685.770.47
Earnings From Equity Investments
85.38---37.5-
Other Non Operating Income (Expenses)
49.35-5.65---0.13
Pretax Income
170.74-58.05-108.55-80.25-26.21
Income Tax Expense
--0.05--
Earnings From Continuing Operations
170.74-58.05-108.6-80.25-26.21
Earnings From Discontinued Operations
-7.16-70.14-2.7--
Net Income
163.58-128.19-111.31-80.25-26.21
Net Income to Common
163.58-128.19-111.31-80.25-26.21
Net Income Growth
-----
Shares Outstanding (Basic)
55532
Shares Outstanding (Diluted)
195532
Shares Change
-0.49%86.29%21.39%-
EPS (Basic)
30.19-23.76-20.73-27.84-11.04
EPS (Diluted)
8.49-23.76-20.73-27.84-11.04
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-69.94-77.83-110.2825.37-26.13
Free Cash Flow Per Share
-3.66-14.42-20.548.80-11.00
Gross Margin
93.90%82.60%57.95%-100.00%
Operating Margin
31.16%-139.91%-1425.79%--2654.80%
Profit Margin
142.10%-333.25%-1389.23%--2620.80%
Free Cash Flow Margin
-60.75%-202.33%-1376.42%--2612.90%
EBITDA
35.9-53.79-114.21-48.52-
EBITDA Margin
31.18%-139.84%---
D&A For EBITDA
0.030.030.020-
EBIT
35.87-53.82-114.23-48.52-26.55
EBIT Margin
31.16%-139.91%---
SEC Filings: 10-K · 10-Q